Premium
Medication use as a surrogate marker of emotional health in long‐term cancer survivors
Author(s) -
Fleishman Stewart B.
Publication year - 2015
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/cncr.29013
Subject(s) - medicine , surrogate endpoint , specialty , cancer , disease , term (time) , psychiatry , differential diagnosis , pathology , physics , quantum mechanics
Evaluation of the pattern of psychiatric medications used by long‐term cancer survivors is an inadequate surrogate marker with which to gauge survivors' emotional health. Specialty‐level assessment and treatment are important for precise differential diagnosis and treatment when central nervous system disease recurrence can mimic psychiatric symptoms.